US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Altimmune, Inc.

5.62

+0.16002.93%

Post-market: 5.650.0300+0.53%19:59 EDT

Volume:3.88M

Turnover:22.01M

Market Cap:455.82M

PE:-4.50

High:5.81

Open:5.48

Low:5.47

Close:5.46

Loading ...

Overview Company News Filings

Altimmune Inc reports results for the quarter ended December 31 - Earnings Summary

Altimmune Q4 2024 GAAP EPS $(0.33), Inline, Sales $5.00K Down From $37.00K YoY, Cash, Cash Equivalents And Short-term Investments Of $131.9M

Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

Immunocore reports fourth quarter and full year 2024 financial results and provides a business update

Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors

THOMSON REUTERS

Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

ALT Resources to Acquire Mining Royalty and Move to AIM

3 Token Unlocks to Watch for The Last Week of February

Altimmune put volume heavy and directionally bearish

Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003

Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF®

Altimmune call volume above normal and directionally bullish

Pfizer and Astellas’ PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) Shows Long-Term Efficacy in First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer (la/mUC)

Altimmune Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

With 56% institutional ownership, Altimmune, Inc. (NASDAQ:ALT) is a favorite amongst the big guns

Simply Wall St.

B.Riley Financial Reaffirms Their Buy Rating on Altimmune (ALT)

Altimmune Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Xilio Therapeutics Announces Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer

Altimmune call volume above normal and directionally bullish

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ALT/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALT\",,,,,undefined,":{"symbol":"ALT","market":"US","secType":"STK","nameCN":"Altimmune, Inc.","latestPrice":5.62,"timestamp":1749240000000,"preClose":5.46,"halted":0,"volume":3875203,"hourTrading":{"tag":"盘后","latestPrice":5.65,"preClose":5.62,"latestTime":"19:59 EDT","volume":49500,"amount":279824.8141,"timestamp":1749254362052},"delay":0,"floatShares":80428500,"shares":81106973,"eps":-1.250036,"marketStatus":"Market Closed","change":0.16,"latestTime":"06-06 16:00:00 EDT","open":5.48,"high":5.805,"low":5.47,"amount":22007569.2522656,"amplitude":0.061355,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.250036,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":5.46,"preHourTrading":{"tag":"盘前","latestPrice":5.4712,"preClose":5.46,"latestTime":"09:24 EDT","volume":12785,"amount":70143.53450499999,"timestamp":1749216248306},"postHourTrading":{"tag":"盘后","latestPrice":5.65,"preClose":5.62,"latestTime":"19:59 EDT","volume":49500,"amount":279824.8141,"timestamp":1749254362052},"volumeRatio":1.2497798097921287,"impliedVol":2.0737,"impliedVolPercentile":0.992},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALT\",,,,,undefined,":{"symbol":"ALT","floatShares":80428500,"roa":"-35.51%","roe":"-57.28%","lyrEps":-1.338795,"volumeRatio":1.2497798097921287,"shares":81106973,"dividePrice":0,"high":5.805,"amplitude":0.061355,"preClose":5.46,"low":5.47,"week52Low":3.553,"pbRate":"3.21","psRate":"22791.06","week52High":11.16,"institutionHeld":0.7753,"latestPrice":5.62,"eps":-1.250036,"divideRate":0,"volume":3875203,"delay":0,"ttmEps":-1.250036,"open":5.48,"prevYearClose":7.21,"prevWeekClose":5.43,"prevMonthClose":5.43,"prevQuarterClose":5,"fiveDayClose":5.43,"twentyDayClose":5.8,"sixtyDayClose":5.55},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALT\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514389592","title":"Altimmune Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2514389592","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514389592?lang=en_us&edition=fundamental","pubTime":"2025-02-27 23:12","pubTimestamp":1740669177,"startTime":"0","endTime":"0","summary":"Altimmune Inc reports results for the quarter ended December 31 - Earnings SummaryAltimmune Inc ALT.OQ reported a quarterly adjusted loss of 33 cents per share for the quarter ended December 31, ident","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL5N3PI234:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT"],"gpt_icon":0},{"id":"2514371805","title":"Altimmune Q4 2024 GAAP EPS $(0.33), Inline, Sales $5.00K Down From $37.00K YoY, Cash, Cash Equivalents And Short-term Investments Of $131.9M","url":"https://stock-news.laohu8.com/highlight/detail?id=2514371805","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514371805?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:03","pubTimestamp":1740657790,"startTime":"0","endTime":"0","summary":"Altimmune (NASDAQ:ALT) reported quarterly losses of $(0.33) per share which met the analyst consensus estimate. This is a 38.89 percent increase over losses of $(0.54) per share from the same period last year.  The","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/02/44002580/altimmune-q4-2024-gaap-eps-0-33-inline-sales-5-00k-down-from-37-00k-yoy-cash-cash-equivalents-and-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Altimmune Q4 2024 GAAP EPS $(0.33), Inline, Sales $5.00K Down From $37.00K YoY, Cash, Cash Equivalents And Short-term Investments Of $131.9M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT"],"gpt_icon":0},{"id":"2514898508","title":"Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514898508","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514898508?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:01","pubTimestamp":1740603660,"startTime":"0","endTime":"0","summary":"- 2025 expected global net product sales of $420 million to $435 million. - VISTAS study of volixibat in PSC expected to complete enrollment in second half 2025; topline data expected 2026. - CTEXLI  approved in the US for cerebrotendinous xanthomatosis. - Conference call to provide business updates today, February 26 at 1:30 p.m. PT/4:30 p.m. ET. FOSTER CITY, Calif., February 26, 2025----Mirum Pharmaceuticals, Inc.  today reported financial results for the fourth quarter and year-end 2024 and provided a business update.\"2024 was another year of significant growth and accomplishments for Mirum and in 2025 we expect this momentum to continue,\" said Chris Peetz, chief executive officer of Mirum. \"We continue to expand the reach of our three commercial medicines within our patient communities and look forward to another year of strong financial performance. On top of this, we are looking forward to multiple upcoming clinical and regulatory milestones, such as PSC where we’re expecting ful","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-fourth-quarter-210100952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1878469433.USD","ALGS","BK4532","GGT","BK4588","BSEP","BK4520","BK4505","IBAT","BK4139","FXS","X","BK4079","FSV","BK4599","BK4006","PSC","BK4516","MIRM","PBC","BK4585","ALT"],"gpt_icon":1},{"id":"2514983992","title":"Immunocore reports fourth quarter and full year 2024 financial results and provides a business update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514983992","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514983992?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:00","pubTimestamp":1740571200,"startTime":"0","endTime":"0","summary":"KIMMTRAK  Q4 net sales of $84.1 million and $310.0 million for full year 2024; continued growth expected in 2025. Executing on KIMMTRAK lifecycle management with two Phase 3 trials  in additional melanoma indications. Advancing PRAME portfolio – first patient randomized in Phase 3 PRISM-MEL-301; enrollment continues in Phase 1/2 trial of brenetafusp combinations in ovarian cancer and NSCLC; first patient dosed in Phase 1 trial of IMC-P115C . First patient dosed in Phase 1/2 trial of IMC-R117C  in colorectal and other gastrointestinal cancers. CTA/IND on track for IMC-S118AI  in 2H 2025 and for IMC-U120AI, our first non-HLA-restricted candidate initially for atopic dermatitis, in 2026. Cash, cash equivalents and marketable securities of $820.4 million as of December 31, 2024. “In 2024, we continued to grow KIMMTRAK sales, execute on our KIMMTRAK lifecycle management program, advance our deep clinical pipeline, and expand into autoimmune diseases, supported by a strong cash position and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/immunocore-reports-fourth-quarter-full-120000489.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4097","MTD","BK4548","BK4147","CTA","LU2065731478.USD","LU2413666699.HKD","ATOM","BK4121","BK4588","CM","IE00B7SZL793.SGD","LU1093756325.SGD","BK4567","BK4585","IE00BFXG0V08.USD","LU1878469433.USD","BK4505","IE0031619046.USD","BK4599","BK4139","BK4533","LU0347712357.USD","ORR","ALT","BK4207","OS","LU2413666426.HKD","IE00B66KJ199.SGD","LU1093756168.USD","LU1721428933.USD","PROC","BK4006","CRS","BK4211","IE00B19Z4B17.USD","IE00BYQQ9H92.USD","PFS","IMCR","BK4007","BK4195"],"gpt_icon":0},{"id":"2514095551","title":"Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2514095551","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514095551?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:30","pubTimestamp":1740486601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nTUA2RLV7N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4548","BK4588","LU0266013472.USD","ALT","LU2433249047.HKD","BK4082","IE00BMPRXR70.SGD","LU0354030438.USD","DXCM","LU1878469433.USD","BK4534","LU2125909247.SGD","LU2211815571.USD","LU0354030511.USD","BK4504","BK4551","BK4585","LU2125909593.SGD","LU1923622614.USD","BK4139","BK4599","IE00BMPRXN33.USD"],"gpt_icon":0},{"id":"2514095239","title":"Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2514095239","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514095239?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:30","pubTimestamp":1740486600,"startTime":"0","endTime":"0","summary":"Ms. Lawver, former Chief Commercial Officer of Dexcom and Global Vice President at Johnson & Johnson responsible for billion-dollar Immunology and Cardiovascular & Metabolism Portfolios over her 20-year career. Mr. Durso led biopharmaceutical company focused on liver disease as former CEO of Intercept Pharmaceuticals, previously oversaw multiple blockbuster franchises including cardiovascular and diabetes during 22-year tenure at Sanofi. GAITHERSBURG, Md., Feb. 25, 2025  -- Altimmune, Inc. , a clinical-stage biopharmaceutical company, today announced the expansion of its Board of Directors with the appointments of Teri Lawver and Jerry Durso.Ms. Lawver stated, “It is an honor to join Altimmune’s Board at such an exciting time in the Company’s evolution. Pemvidutide has shown what I believe to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/seasoned-biopharmaceutical-industry-executives-teri-123000035.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4599","ALT","BK4139","DXCM","LU1878469433.USD"],"gpt_icon":0},{"id":"2514509829","title":"FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2514509829","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514509829?lang=en_us&edition=fundamental","pubTime":"2025-02-25 19:45","pubTimestamp":1740483900,"startTime":"0","endTime":"0","summary":"Acceptance based on results from the KEYNOTE-689 trial: the first Phase 3 trial to demonstrate significant improvement in event-free survival in the neoadjuvant and adjuvant setting for an anti-PD-1 therapy in earlier stages of head and neck squamous cell carcinoma. RAHWAY, N.J., February 25, 2025----Merck , known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration  has accepted for priority review a new supplemental Biologics License Application  seeking approval for KEYTRUDA , Merck’s anti-PD-1 therapy, for the treatment of patients with resectable locally advanced head and neck squamous cell carcinoma  as neoadjuvant treatment, then continued as adjuvant treatment in combination with standard of care radiotherapy with or without cisplatin and then as a single agent. The FDA has set a Prescription Drug User Fee Act , or target action, date of June 23, 2025.KEYTRUDA is currently approved as monotherapy and in combination regimens for a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-grants-priority-review-merck-114500312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1037948541.HKD","BK4533","LU1291159041.SGD","LU2468319806.SGD","SG9999002224.SGD","LU0965509101.SGD","MRK","LU1066051498.USD","LU0456854461.SGD","SG9999013999.USD","CRC","LU0238689110.USD","CPS","SMP","IE00B1BXHZ80.USD","LU2106854487.HKD","IE00BLSP4239.USD","HSCT","LU0265550946.USD","BTC","LU1585245621.USD","LU1116320737.USD","IE00BBT3K403.USD","BK4534","LU2089984988.USD","SG9999015358.SGD","LU0320765646.SGD","LU1093756325.SGD","CRT","BK4585","LU0006306889.USD","LU1989771016.USD","ALT","LU1989772923.USD","HCC","LU0122379950.USD","LU1929549753.HKD","RCC","LU2361045086.USD","DM","AEIS","LU2023250504.SGD","LU1878469433.USD","BCG","LU0861579265.USD","BK4139","LU0265550359.USD","IE00BJT1NW94.SGD","LU1066051225.USD","LU1066053197.SGD"],"gpt_icon":0},{"id":"2513169047","title":"ALT Resources to Acquire Mining Royalty and Move to AIM","url":"https://stock-news.laohu8.com/highlight/detail?id=2513169047","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513169047?lang=en_us&edition=fundamental","pubTime":"2025-02-24 15:21","pubTimestamp":1740381705,"startTime":"0","endTime":"0","summary":"ACP Energy PLC ( ($GB:ALTR) ) just unveiled an update. ALT Resources PLC has announced a conditional agreement to acquire a cash-generative mining ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alt-resources-to-acquire-mining-royalty-and-move-to-aim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alt-resources-to-acquire-mining-royalty-and-move-to-aim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALT","BK4139","LU1878469433.USD","BK4557","AIM","BK4599"],"gpt_icon":0},{"id":"2513752100","title":"3 Token Unlocks to Watch for The Last Week of February","url":"https://stock-news.laohu8.com/highlight/detail?id=2513752100","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513752100?lang=en_us&edition=fundamental","pubTime":"2025-02-24 00:30","pubTimestamp":1740328200,"startTime":"0","endTime":"0","summary":"On February 28, 25.61 million PORTAL tokens will unlock, representing roughly $3.58 million in value.Scheduled for February 25, 240.80 million ALT tokens will unlock, valued at approximately $11.30 million.On February 27, NFPrompt will release 14.51 million tokens, equating to around $1.83 million.Token unlocks are events when blockchain projects release previously restricted tokens to the market. These events are carefully planned to manage market impact and volatility.Often, these token unlocks lead to notable price movements. Here are three major token unlocks scheduled for the upcoming week:. Number of Tokens to be Unlocked: 25.61 million PORTAL . Portal is the native utility token for a crosschain Web3 gaming platform that unites gamers and developers across multiple blockchain networks. The upcoming unlock will release tokens from several rounds of allocation.For instance, the Team & Advisors allocation will increase by approximately 920,000 tokens, while the Treasury allocation ","market":"us","thumbnail":"https://beincrypto.com/wp-content/uploads/2023/01/bic_tokens_neutral_1-850x478.png","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2023/01/bic_tokens_neutral_1-850x478.png"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/token-unlocks-last-week-of-february/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["LU1878469433.USD","BK4139","ALT","BK4599"],"gpt_icon":0},{"id":"2512894486","title":"Altimmune put volume heavy and directionally bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2512894486","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512894486?lang=en_us&edition=fundamental","pubTime":"2025-02-19 23:15","pubTimestamp":1739978108,"startTime":"0","endTime":"0","summary":"Bearish flow noted in Altimmune (ALT) with 1,259 puts trading, or 5x expected. Most active are Jun-25 6 puts and Feb-25 6.5 puts, with total volume...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/altimmune-put-volume-heavy-and-directionally-bearish-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/altimmune-put-volume-heavy-and-directionally-bearish-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","BK4139","LU1878469433.USD","ALT"],"gpt_icon":0},{"id":"2512156537","title":"Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003","url":"https://stock-news.laohu8.com/highlight/detail?id=2512156537","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512156537?lang=en_us&edition=fundamental","pubTime":"2025-02-18 19:45","pubTimestamp":1739879100,"startTime":"0","endTime":"0","summary":"— Day 90 biopsy data reported from first 3 participants dosed in Phase 1/2 INSPIRE DUCHENNE trial ——Average microdystrophin expression of 110% (N=3) and significant improvements in multiple additional","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/18/3027621/0/en/Solid-Biosciences-Reports-Positive-Initial-Clinical-Data-from-Next-Generation-Duchenne-Gene-Therapy-Candidate-SGT-003.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FA","BK4535","BK4130","ALT","AST","BK4539","BK4139","BK4179","BK4599","AESI","GGT","SLDB","LU1878469433.USD"],"gpt_icon":0},{"id":"2510358376","title":"Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF®","url":"https://stock-news.laohu8.com/highlight/detail?id=2510358376","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510358376?lang=en_us&edition=fundamental","pubTime":"2025-02-12 01:59","pubTimestamp":1739296740,"startTime":"0","endTime":"0","summary":"WASHINGTON, Feb. 11, 2025  -- 60 Degrees Pharmaceuticals, Inc.  , pharmaceutical company today announced that the United States Food and Drug Administration  does not object to the Company’s plan to import KODATEF  from Australia as a one-time, preemptive measure against any near-term disruption in the U.S. supply of ARAKODA .ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years and older in the United States  It is sold under the brand name KODATEF in Australia, where it is indicated for the prevention of malaria in adults 18 years of age and above. The two products are identical in their dosing regimens, mechanisms of action, safety and efficacy profiles, and other clinical features. KODATEF is not approved for use in the U.S.Demand for ARAKODA has been steadily growing in recent months as awareness and use of the product has expanded across the U.S. The Company is taking the proactive step of importing KODATEF as a demonstration of its long-st","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sixty-degrees-pharmaceuticals-ensure-continuity-175900817.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SXTPW","BK4139","ALT","BK4599","SXTP","BK4007","LU1878469433.USD"],"gpt_icon":0},{"id":"2510334170","title":"Altimmune call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2510334170","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510334170?lang=en_us&edition=fundamental","pubTime":"2025-02-12 00:46","pubTimestamp":1739292373,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Altimmune (ALT) with 5,177 calls trading, 2x expected, and implied vol increasing over 26 points to 77.40%. Jun-25 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/altimmune-call-volume-above-normal-and-directionally-bullish-22?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/altimmune-call-volume-above-normal-and-directionally-bullish-22?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALT","BK4139","LU1878469433.USD","BK4599"],"gpt_icon":0},{"id":"2510815573","title":"Pfizer and Astellas’ PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) Shows Long-Term Efficacy in First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer (la/mUC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2510815573","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510815573?lang=en_us&edition=fundamental","pubTime":"2025-02-11 06:00","pubTimestamp":1739224800,"startTime":"0","endTime":"0","summary":"Enfortumab vedotin plus pembrolizumab continues to demonstrate superior efficacy versus chemotherapy in a broad population, reinforcing the combination as standard of care in first-line treatment of la/mUC. At nearly 30 months of follow-up in the Phase 3 EV-302 trial, the combination doubled median overall survival and progression-free survival compared to chemotherapy, with no new safety signals identified. NEW YORK & TOKYO, February 10, 2025----Pfizer Inc.  and Astellas Pharma Inc.  today announced additional follow-up results from the Phase 3 EV-302 clinical trial  evaluating the efficacy and safety of PADCEV  , a Nectin-4 directed antibody-drug conjugate, plus KEYTRUDA , a PD-1 inhibitor, in patients with previously untreated locally advanced or metastatic urothelial cancer . The results showed a sustained overall survival  and progression-free survival  benefit consistent with the findings of the primary analysis after an additional 12 months of follow-up .1,2 These data will be p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b68b91779c1270fe944d25cf0021e5aa","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-astellas-padcev-enfortumab-vedotin-220000915.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0031619046.USD","IE0009355771.USD","LU1934455863.HKD","ALPMF","BK4097","BK4080","LU0122379950.USD","BK4559","LU1585245621.USD","LU0238689110.USD","OS","PFE","LU1883839398.USD","LU1571399168.USD","ALPMY","LU1037948897.HKD","PFS","LU1162221912.USD","MRK","ADC","BK4534","BK4195","LU0320765646.SGD","LU1929549753.HKD","LU0321505868.SGD","IE00B2B36J28.USD","LU2089984988.USD","LU0861579265.USD","LU1023059063.AUD","LU0985481810.HKD","BK4157","IE00B66KJ199.SGD","BK4585","LU1057294990.SGD","AST","LU1093756168.USD","TEN","LU0321505439.SGD","LU1699723380.USD","LU1934455277.USD","SG9999013999.USD","BK4516","AEIS","LU0208291251.USD","LU1983299246.USD","LU0289739699.SGD","IE00BLSP4239.USD","LU1116320737.USD","BK4007","ALT","LU0234572021.USD"],"gpt_icon":1},{"id":"2509231760","title":"Altimmune Price Target Maintained With a $12.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2509231760","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509231760?lang=en_us&edition=fundamental","pubTime":"2025-02-06 01:23","pubTimestamp":1738776180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 05, 2025 12:23 ET (17:23 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT"],"gpt_icon":0},{"id":"2508496431","title":"With 56% institutional ownership, Altimmune, Inc. (NASDAQ:ALT) is a favorite amongst the big guns","url":"https://stock-news.laohu8.com/highlight/detail?id=2508496431","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508496431?lang=en_us&edition=fundamental","pubTime":"2025-02-04 18:10","pubTimestamp":1738663809,"startTime":"0","endTime":"0","summary":"Institutions' substantial holdings in Altimmune implies that they have significant influence over the company's share price. A total of 25 investors have a majority stake in the company with 47% ownership. Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a company. To get a sense of who is truly in control of Altimmune, Inc. , it is important to understand the ownership structure of the business. With 56% stake, institutions possess the maximum shares in the company. In other words, the group stands to gain the most  from their investment into the company.Since institutional have access to huge amounts of capital, their market moves tend to receive a lot of scrutiny by retail or individual investors. Hence, having a considerable amount of institutional money invested in a company is often regarded as a desirable trait.While studying institutional ownership for a company can add value to your research, it is also a good prac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/56-institutional-ownership-altimmune-inc-101009913.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USAW.SI","TSYW.SI","TQQQ","BK4585","NVIW.SI","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4588","ALT","QID","BK4112","BK4139","LU2210149790.SGD","LU1878469433.USD","LU2095319765.USD","IE00BGHQF748.EUR","PSQ","BK4599","LU2210150020.SGD","SQQQ","NDAQ","QLD",".IXIC","IE00B3QW5Z07.USD","NQmain","MNQmain","USJW.SI"],"gpt_icon":1},{"id":"2506132225","title":"B.Riley Financial Reaffirms Their Buy Rating on Altimmune (ALT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2506132225","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506132225?lang=en_us&edition=fundamental","pubTime":"2025-01-28 21:16","pubTimestamp":1738070168,"startTime":"0","endTime":"0","summary":"B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Altimmune (ALT – Research Report) yesterday and set a price target of $20.00. T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/b-riley-financial-reaffirms-their-buy-rating-on-altimmune-alt-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/b-riley-financial-reaffirms-their-buy-rating-on-altimmune-alt-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALT"],"gpt_icon":0},{"id":"2505774400","title":"Altimmune Price Target Maintained With a $12.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2505774400","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505774400?lang=en_us&edition=fundamental","pubTime":"2025-01-23 02:33","pubTimestamp":1737570780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 22, 2025 13:33 ET (18:33 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT"],"gpt_icon":0},{"id":"2505738151","title":"Xilio Therapeutics Announces Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2505738151","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505738151?lang=en_us&edition=fundamental","pubTime":"2025-01-22 06:05","pubTimestamp":1737497100,"startTime":"0","endTime":"0","summary":"27% preliminary response rate observed in heavily pre-treated microsatellite stable colorectal cancer (MSS CRC) patients without liver metastases Responses were accompanied by decreases in levels of c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/21/3013106/0/en/Xilio-Therapeutics-Announces-Initial-Phase-2-Data-for-Vilastobart-XTX101-a-Tumor-Activated-Anti-CTLA-4-in-Combination-with-Atezolizumab-in-Patients-with-Metastatic-Microsatellite-S.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023057109.AUD","LU0359202008.SGD","BK4531","SG9999011746.SGD","BK4599","BK4500","BK4588","IE00B12V2V27.USD","BK4548","L","ALT","BK4108","BK4526","BK4107","IE00BYTNYN87.SGD","LU1878469433.USD","BK4571","IE00BYQNZ168.SGD","BK4535","BK4008","AST","BK4552","LENZ","LU0359201612.USD","BK4585","BK4563","BK4139","BK4509","BK4565","LU0053666078.USD","01698","CEA","ORR","TME","LU2039709279.SGD"],"gpt_icon":0},{"id":"2504197498","title":"Altimmune call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2504197498","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504197498?lang=en_us&edition=fundamental","pubTime":"2025-01-18 02:05","pubTimestamp":1737137116,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Altimmune (ALT) with 6,038 calls trading, 1.6x expected, and implied vol increasing over 8 points to 89.06%. Mar-25...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/altimmune-call-volume-above-normal-and-directionally-bullish-21?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/altimmune-call-volume-above-normal-and-directionally-bullish-21?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1878469433.USD","BK4139","BK4599","ALT"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":110,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"ALT","fiscalQuarterEnding":"2025/03","expectedEps":-0.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2025-02-27","symbol":"ALT","fiscalQuarterEnding":"2024/12","expectedEps":-0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-0.33},{"market":"US","date":"2024-11-12","symbol":"ALT","fiscalQuarterEnding":"2024/09","expectedEps":-0.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2024-08-08","symbol":"ALT","fiscalQuarterEnding":"2024/06","expectedEps":-0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2024-05-09","symbol":"ALT","fiscalQuarterEnding":"2024/03","expectedEps":-0.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.34}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.625,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1740715200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALT","date":"2025-06-06","current":-4.907403,"percent":0.609261,"low":-46.273572,"twenty":-9.1665,"median":-5.562525,"eighty":-3.341904,"high":-1.406077,"avg":-6.784482,"sd":5.441071,"marketCap":442844072},"quantilePoints":[{"date":"2020-06-12","current":-8.524658,"twenty":-2.245297,"median":-0.858043,"eighty":-0.538857,"marketCap":190172108},{"date":"2020-06-19","current":-8.366375,"twenty":-2.282153,"median":-0.861395,"eighty":-0.539667,"marketCap":186641061},{"date":"2020-06-26","current":-11.984267,"twenty":-2.31901,"median":-0.864935,"eighty":-0.540746,"marketCap":267350709},{"date":"2020-07-02","current":-11.780761,"twenty":-2.329329,"median":-0.871046,"eighty":-0.542905,"marketCap":262810791},{"date":"2020-07-10","current":-25.268714,"twenty":-2.37798,"median":-0.876338,"eighty":-0.546142,"marketCap":563706447},{"date":"2020-07-17","current":-39.87374,"twenty":-2.464961,"median":-0.882047,"eighty":-0.551269,"marketCap":889522282},{"date":"2020-07-24","current":-35.658198,"twenty":-2.511587,"median":-0.882106,"eighty":-0.555317,"marketCap":795479975},{"date":"2020-07-31","current":-36.979902,"twenty":-2.577308,"median":-0.889057,"eighty":-0.558825,"marketCap":824965187},{"date":"2020-08-07","current":-38.092917,"twenty":-2.657548,"median":-0.893652,"eighty":-0.56016,"marketCap":849794839},{"date":"2020-08-14","current":-22.525667,"twenty":-2.805189,"median":-0.898031,"eighty":-0.561197,"marketCap":803907295},{"date":"2020-08-21","current":-21.96438,"twenty":-2.869381,"median":-0.902327,"eighty":-0.561253,"marketCap":783875813},{"date":"2020-08-28","current":-16.098684,"twenty":-2.956041,"median":-0.905258,"eighty":-0.561524,"marketCap":574537930},{"date":"2020-09-04","current":-11.35679,"twenty":-3.087213,"median":-0.907254,"eighty":-0.563087,"marketCap":405306837},{"date":"2020-09-11","current":-11.046146,"twenty":-3.177503,"median":-0.908968,"eighty":-0.565026,"marketCap":394220407},{"date":"2020-09-18","current":-12.900875,"twenty":-3.305887,"median":-0.909901,"eighty":-0.568591,"marketCap":460412915},{"date":"2020-09-25","current":-11.804484,"twenty":-3.450319,"median":-0.915777,"eighty":-0.568832,"marketCap":421284339},{"date":"2020-10-02","current":-11.850167,"twenty":-3.626847,"median":-0.919185,"eighty":-0.56887,"marketCap":422914696},{"date":"2020-10-09","current":-11.301971,"twenty":-4.67722,"median":-0.919185,"eighty":-0.570264,"marketCap":403350408},{"date":"2020-10-16","current":-11.850167,"twenty":-4.848628,"median":-0.928329,"eighty":-0.572047,"marketCap":422914696},{"date":"2020-10-23","current":-10.963917,"twenty":-5.046072,"median":-0.930791,"eighty":-0.572259,"marketCap":391285764},{"date":"2020-10-30","current":-10.461404,"twenty":-5.241612,"median":-0.937755,"eighty":-0.572714,"marketCap":373351833},{"date":"2020-11-06","current":-11.375064,"twenty":-5.335212,"median":-0.937755,"eighty":-0.576558,"marketCap":405958980},{"date":"2020-11-13","current":-7.837321,"twenty":-5.405412,"median":-0.941735,"eighty":-0.580401,"marketCap":333237614},{"date":"2020-11-20","current":-7.210645,"twenty":-5.429046,"median":-0.942397,"eighty":-0.581491,"marketCap":306591763},{"date":"2020-11-27","current":-8.139054,"twenty":-5.509728,"median":-0.943742,"eighty":-0.583694,"marketCap":346067098},{"date":"2020-12-04","current":-9.539405,"twenty":-5.616013,"median":-0.94704,"eighty":-0.584245,"marketCap":405609060},{"date":"2020-12-11","current":-9.260882,"twenty":-5.690893,"median":-0.956324,"eighty":-0.58732,"marketCap":393766460},{"date":"2020-12-18","current":-9.647719,"twenty":-5.791553,"median":-0.957434,"eighty":-0.588089,"marketCap":410214516},{"date":"2020-12-24","current":-8.858572,"twenty":-5.840973,"median":-0.958492,"eighty":-0.589596,"marketCap":376660482},{"date":"2020-12-31","current":-9.807293,"twenty":-5.850013,"median":-0.965609,"eighty":-0.590601,"marketCap":416999468},{"date":"2021-01-08","current":-12.276505,"twenty":-5.920213,"median":-0.96954,"eighty":-0.591133,"marketCap":521988696},{"date":"2021-01-15","current":-11.24187,"twenty":-6.051347,"median":-0.974894,"eighty":-0.591932,"marketCap":477996731},{"date":"2021-01-22","current":-12.476476,"twenty":-6.084014,"median":-0.976283,"eighty":-0.592399,"marketCap":530491345},{"date":"2021-01-29","current":-12.415615,"twenty":-6.19479,"median":-0.981857,"eighty":-0.595339,"marketCap":527903582},{"date":"2021-02-05","current":-15.962934,"twenty":-6.336734,"median":-0.985303,"eighty":-0.59962,"marketCap":678733177},{"date":"2021-02-12","current":-19.318976,"twenty":-7.087016,"median":-0.988821,"eighty":-0.59962,"marketCap":821429804},{"date":"2021-02-19","current":-19.936279,"twenty":-7.210645,"median":-0.990004,"eighty":-0.59962,"marketCap":847677111},{"date":"2021-02-26","current":-12.019122,"twenty":-7.357643,"median":-0.992005,"eighty":-0.59962,"marketCap":589471561},{"date":"2021-03-05","current":-9.757054,"twenty":-7.837321,"median":-0.998372,"eighty":-0.603077,"marketCap":478529611},{"date":"2021-03-12","current":-12.637421,"twenty":-8.231895,"median":-1.002367,"eighty":-0.603464,"marketCap":619795694},{"date":"2021-03-19","current":-12.381053,"twenty":-8.510418,"median":-1.005411,"eighty":-0.603464,"marketCap":607222273},{"date":"2021-03-26","current":-10.443215,"twenty":-8.587786,"median":-1.00739,"eighty":-0.605274,"marketCap":512182002},{"date":"2021-04-01","current":-10.556318,"twenty":-8.78138,"median":-1.016675,"eighty":-0.605274,"marketCap":517729100},{"date":"2021-04-09","current":-9.726893,"twenty":-9.292271,"median":-1.021158,"eighty":-0.6069,"marketCap":477050385},{"date":"2021-04-16","current":-9.251859,"twenty":-9.464501,"median":-1.024724,"eighty":-0.607307,"marketCap":453752575},{"date":"2021-04-23","current":-9.380043,"twenty":-9.464501,"median":-1.029527,"eighty":-0.607307,"marketCap":460039286},{"date":"2021-04-30","current":-10.910709,"twenty":-9.499174,"median":-1.032222,"eighty":-0.607307,"marketCap":535110005},{"date":"2021-05-07","current":-10.005881,"twenty":-9.568548,"median":-1.035738,"eighty":-0.608615,"marketCap":490733225},{"date":"2021-05-14","current":-10.088824,"twenty":-9.690182,"median":-1.043356,"eighty":-0.610709,"marketCap":494801097},{"date":"2021-05-21","current":-8.930849,"twenty":-9.656014,"median":-1.045001,"eighty":-0.612319,"marketCap":536054794},{"date":"2021-05-28","current":-8.0639,"twenty":-9.614543,"median":-1.047082,"eighty":-0.613503,"marketCap":484018069},{"date":"2021-06-04","current":-8.255139,"twenty":-9.601725,"median":-1.054534,"eighty":-0.614487,"marketCap":495496759},{"date":"2021-06-11","current":-9.160335,"twenty":-9.601725,"median":-1.060147,"eighty":-0.617301,"marketCap":549829222},{"date":"2021-06-18","current":-10.18665,"twenty":-9.645972,"median":-1.061987,"eighty":-0.619095,"marketCap":611431522},{"date":"2021-06-25","current":-10.250396,"twenty":-9.735941,"median":-1.064048,"eighty":-0.619675,"marketCap":615257751},{"date":"2021-07-02","current":-5.953899,"twenty":-9.75253,"median":-1.073166,"eighty":-0.622777,"marketCap":357369863},{"date":"2021-07-09","current":-5.871029,"twenty":-9.740466,"median":-1.078488,"eighty":-0.625409,"marketCap":352395764},{"date":"2021-07-16","current":-5.603295,"twenty":-9.713792,"median":-1.081387,"eighty":-0.626526,"marketCap":336325599},{"date":"2021-07-23","current":-5.660666,"twenty":-9.692161,"median":-1.084345,"eighty":-0.626829,"marketCap":339769206},{"date":"2021-07-30","current":-5.781784,"twenty":-9.672603,"median":-1.09804,"eighty":-0.627284,"marketCap":347039042},{"date":"2021-08-06","current":-6.53399,"twenty":-9.646554,"median":-1.106702,"eighty":-0.627284,"marketCap":392188554},{"date":"2021-08-13","current":-6.989861,"twenty":-9.629384,"median":-1.114155,"eighty":-0.627315,"marketCap":475890082},{"date":"2021-08-20","current":-7.373664,"twenty":-9.603233,"median":-1.117881,"eighty":-0.628565,"marketCap":502020486},{"date":"2021-08-27","current":-8.542517,"twenty":-9.583629,"median":-1.12906,"eighty":-0.630603,"marketCap":581599443},{"date":"2021-09-03","current":-9.554361,"twenty":-9.558349,"median":-1.132786,"eighty":-0.630952,"marketCap":650488690},{"date":"2021-09-10","current":-9.775338,"twenty":-9.591169,"median":-1.136512,"eighty":-0.630952,"marketCap":665533468},{"date":"2021-09-17","current":-8.862353,"twenty":-9.605176,"median":-1.137989,"eighty":-0.631686,"marketCap":603374780},{"date":"2021-09-24","current":-8.705343,"twenty":-9.600447,"median":-1.155144,"eighty":-0.635355,"marketCap":592685069},{"date":"2021-10-01","current":-6.949155,"twenty":-9.591169,"median":-1.16462,"eighty":-0.638289,"marketCap":473118675},{"date":"2021-10-08","current":-7.077089,"twenty":-9.559679,"median":-1.173775,"eighty":-0.638289,"marketCap":481828810},{"date":"2021-10-15","current":-6.984046,"twenty":-9.554182,"median":-1.181272,"eighty":-0.638815,"marketCap":475494167},{"date":"2021-10-22","current":-6.699101,"twenty":-9.550655,"median":-1.192207,"eighty":-0.641115,"marketCap":456094321},{"date":"2021-10-29","current":-6.280407,"twenty":-9.538907,"median":-1.192406,"eighty":-0.641912,"marketCap":427588426},{"date":"2021-11-05","current":-6.303668,"twenty":-9.536915,"median":-1.195875,"eighty":-0.642691,"marketCap":429172087},{"date":"2021-11-12","current":-5.254536,"twenty":-9.534318,"median":-1.207066,"eighty":-0.645626,"marketCap":440449772},{"date":"2021-11-19","current":-4.989681,"twenty":-9.517742,"median":-1.21849,"eighty":-0.645626,"marketCap":418248884},{"date":"2021-11-26","current":-4.928196,"twenty":-9.492985,"median":-1.222217,"eighty":-0.645626,"marketCap":413095106},{"date":"2021-12-03","current":-4.483618,"twenty":-9.492985,"median":-1.234811,"eighty":-0.645626,"marketCap":375829329},{"date":"2021-12-10","current":-4.455241,"twenty":-9.478066,"median":-1.237122,"eighty":-0.645626,"marketCap":373450662},{"date":"2021-12-17","current":-4.426864,"twenty":-9.474354,"median":-1.242711,"eighty":-0.645626,"marketCap":371071995},{"date":"2021-12-23","current":-4.351191,"twenty":-9.464501,"median":-1.250163,"eighty":-0.64856,"marketCap":364728884},{"date":"2021-12-31","current":-4.332272,"twenty":-9.444757,"median":-1.266932,"eighty":-0.649294,"marketCap":363143107},{"date":"2022-01-07","current":-3.916072,"twenty":-9.429228,"median":-1.270658,"eighty":-0.649294,"marketCap":328255996},{"date":"2022-01-14","current":-3.707971,"twenty":-9.419545,"median":-1.300468,"eighty":-0.649294,"marketCap":310812440},{"date":"2022-01-21","current":-3.305959,"twenty":-9.395156,"median":-1.357281,"eighty":-0.649294,"marketCap":277114663},{"date":"2022-01-28","current":-3.40528,"twenty":-9.375518,"median":-1.896273,"eighty":-0.649294,"marketCap":285439996},{"date":"2022-02-04","current":-3.622839,"twenty":-9.356009,"median":-2.181903,"eighty":-0.649294,"marketCap":303676441},{"date":"2022-02-11","current":-3.632298,"twenty":-9.294535,"median":-2.226131,"eighty":-0.651495,"marketCap":304469329},{"date":"2022-02-18","current":-3.339066,"twenty":-9.255468,"median":-2.240874,"eighty":-0.652962,"marketCap":279889774},{"date":"2022-02-25","current":-3.599191,"twenty":-9.25041,"median":-2.262988,"eighty":-0.65443,"marketCap":301694218},{"date":"2022-03-04","current":-3.277582,"twenty":-9.216158,"median":-2.281416,"eighty":-0.656631,"marketCap":274735996},{"date":"2022-03-11","current":-3.29177,"twenty":-9.164959,"median":-2.299844,"eighty":-0.656631,"marketCap":275925330},{"date":"2022-03-18","current":-3.187041,"twenty":-9.152685,"median":-2.321958,"eighty":-0.656631,"marketCap":309429796},{"date":"2022-03-25","current":-2.824576,"twenty":-9.120812,"median":-2.329329,"eighty":-0.656889,"marketCap":274238058},{"date":"2022-04-01","current":-2.749431,"twenty":-9.069815,"median":-2.351443,"eighty":-0.658485,"marketCap":266942209},{"date":"2022-04-08","current":-2.510734,"twenty":-9.026468,"median":-2.395671,"eighty":-0.660299,"marketCap":243767162},{"date":"2022-04-14","current":-2.31182,"twenty":-9.002244,"median":-2.403042,"eighty":-0.660299,"marketCap":224454623},{"date":"2022-04-22","current":-2.006819,"twenty":-8.981208,"median":-2.373557,"eighty":-0.660299,"marketCap":194842063},{"date":"2022-04-29","current":-1.997978,"twenty":-8.97802,"median":-2.3367,"eighty":-0.660463,"marketCap":193983728},{"date":"2022-05-06","current":-1.913993,"twenty":-8.974196,"median":-2.325643,"eighty":-0.661689,"marketCap":185829544},{"date":"2022-05-13","current":-2.19104,"twenty":-8.962867,"median":-2.314587,"eighty":-0.663967,"marketCap":222734186},{"date":"2022-05-20","current":-2.131593,"twenty":-8.93653,"median":-2.296159,"eighty":-0.664701,"marketCap":216691010},{"date":"2022-05-27","current":-2.13584,"twenty":-8.925681,"median":-2.280878,"eighty":-0.66787,"marketCap":217122666},{"date":"2022-06-03","current":-2.309934,"twenty":-8.905008,"median":-2.27773,"eighty":-0.668807,"marketCap":234820537},{"date":"2022-06-10","current":-3.630503,"twenty":-8.886226,"median":-2.28299,"eighty":-0.668883,"marketCap":369065367},{"date":"2022-06-17","current":-3.830074,"twenty":-8.882388,"median":-2.299844,"eighty":-0.671304,"marketCap":389353170},{"date":"2022-06-24","current":-4.369342,"twenty":-8.86636,"median":-2.31182,"eighty":-0.671304,"marketCap":444173406},{"date":"2022-07-01","current":-4.781223,"twenty":-8.859328,"median":-2.321958,"eighty":-0.671304,"marketCap":486043980},{"date":"2022-07-08","current":-5.379938,"twenty":-8.843395,"median":-2.329329,"eighty":-0.672112,"marketCap":546907391},{"date":"2022-07-15","current":-4.810947,"twenty":-8.833277,"median":-2.3367,"eighty":-0.673733,"marketCap":489065568},{"date":"2022-07-22","current":-5.554032,"twenty":-8.79056,"median":-2.3883,"eighty":-0.674765,"marketCap":564605263},{"date":"2022-07-29","current":-5.099688,"twenty":-8.752462,"median":-2.431168,"eighty":-0.674972,"marketCap":518418135},{"date":"2022-08-05","current":-5.26529,"twenty":-8.743932,"median":-2.458327,"eighty":-0.677129,"marketCap":535252696},{"date":"2022-08-12","current":-8.685942,"twenty":-8.727192,"median":-2.479782,"eighty":-0.678611,"marketCap":841987671},{"date":"2022-08-19","current":-8.585874,"twenty":-8.767651,"median":-2.479782,"eighty":-0.678611,"marketCap":832287353},{"date":"2022-08-26","current":-9.231316,"twenty":-8.857064,"median":-2.479782,"eighty":-0.678611,"marketCap":894854409},{"date":"2022-09-02","current":-11.212671,"twenty":-8.915344,"median":-2.479782,"eighty":-0.678611,"marketCap":1086920721},{"date":"2022-09-09","current":-9.996839,"twenty":-8.976745,"median":-2.479782,"eighty":-0.678611,"marketCap":969061848},{"date":"2022-09-16","current":-6.839679,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":663016789},{"date":"2022-09-23","current":-6.189234,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":599964717},{"date":"2022-09-30","current":-6.453807,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":625611519},{"date":"2022-10-07","current":-5.28636,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":512442952},{"date":"2022-10-14","current":-5.256037,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":509503508},{"date":"2022-10-21","current":-5.422815,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":525670447},{"date":"2022-10-28","current":-6.453807,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":625611519},{"date":"2022-11-04","current":-5.983796,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":580050148},{"date":"2022-11-11","current":-6.042666,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":525366485},{"date":"2022-11-18","current":-4.996929,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":434447121},{"date":"2022-11-25","current":-5.138245,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":446733522},{"date":"2022-12-02","current":-6.376172,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":554362390},{"date":"2022-12-09","current":-5.709161,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":496370580},{"date":"2022-12-16","current":-6.489225,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":564191510},{"date":"2022-12-23","current":-8.665489,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":753402078},{"date":"2022-12-30","current":-9.298584,"twenty":-9.046009,"median":-2.479782,"eighty":-0.678611,"marketCap":808445152},{"date":"2023-01-06","current":-8.077615,"twenty":-9.046009,"median":-2.550468,"eighty":-0.678611,"marketCap":702290652},{"date":"2023-01-13","current":-9.208142,"twenty":-9.082964,"median":-2.674285,"eighty":-0.678611,"marketCap":800581856},{"date":"2023-01-20","current":-8.111531,"twenty":-9.082964,"median":-2.74501,"eighty":-0.678611,"marketCap":705239388},{"date":"2023-01-27","current":-7.478436,"twenty":-9.082964,"median":-2.834635,"eighty":-0.678611,"marketCap":650196314},{"date":"2023-02-03","current":-8.569394,"twenty":-9.082964,"median":-3.041104,"eighty":-0.682837,"marketCap":745047326},{"date":"2023-02-10","current":-7.591488,"twenty":-9.082964,"median":-3.089794,"eighty":-0.692599,"marketCap":660025434},{"date":"2023-02-17","current":-6.760551,"twenty":-9.082964,"median":-3.29177,"eighty":-0.706713,"marketCap":587781399},{"date":"2023-02-24","current":-6.771856,"twenty":-9.082964,"median":-3.329607,"eighty":-0.719867,"marketCap":588764311},{"date":"2023-03-03","current":-6.742082,"twenty":-9.082964,"median":-3.358746,"eighty":-0.742102,"marketCap":571141998},{"date":"2023-03-10","current":-6.032389,"twenty":-9.082964,"median":-3.414739,"eighty":-0.768114,"marketCap":511021788},{"date":"2023-03-17","current":-6.404687,"twenty":-9.082964,"median":-3.495141,"eighty":-0.78253,"marketCap":542560259},{"date":"2023-03-24","current":-2.513011,"twenty":-9.082964,"median":-3.5046,"eighty":-0.796016,"marketCap":212884679},{"date":"2023-03-31","current":-2.454839,"twenty":-9.080548,"median":-3.499871,"eighty":-0.802556,"marketCap":207956793},{"date":"2023-04-06","current":-2.251239,"twenty":-9.080548,"median":-3.499871,"eighty":-0.804482,"marketCap":190709192},{"date":"2023-04-14","current":-2.681708,"twenty":-9.082964,"median":-3.5046,"eighty":-0.809804,"marketCap":227175549},{"date":"2023-04-21","current":-3.33323,"twenty":-9.082964,"median":-3.5046,"eighty":-0.816048,"marketCap":282367873},{"date":"2023-04-28","current":-2.885309,"twenty":-9.085381,"median":-3.51872,"eighty":-0.82152,"marketCap":244423150},{"date":"2023-05-05","current":-2.873674,"twenty":-9.085381,"median":-3.51872,"eighty":-0.831857,"marketCap":243437573},{"date":"2023-05-12","current":-3.100543,"twenty":-9.085381,"median":-3.51872,"eighty":-0.840814,"marketCap":262656329},{"date":"2023-05-19","current":-2.569103,"twenty":-9.085381,"median":-3.51872,"eighty":-0.844264,"marketCap":219290931},{"date":"2023-05-26","current":-2.431202,"twenty":-9.085381,"median":-3.51872,"eighty":-0.854355,"marketCap":207520115},{"date":"2023-06-02","current":-2.396553,"twenty":-9.085381,"median":-3.51872,"eighty":-0.858045,"marketCap":204562584},{"date":"2023-06-09","current":-2.361904,"twenty":-9.085381,"median":-3.51872,"eighty":-0.86619,"marketCap":201605053},{"date":"2023-06-16","current":-2.361904,"twenty":-9.085381,"median":-3.51872,"eighty":-0.879261,"marketCap":201605053},{"date":"2023-06-23","current":-2.402328,"twenty":-9.087797,"median":-3.53284,"eighty":-0.88307,"marketCap":205055506},{"date":"2023-06-30","current":-2.021189,"twenty":-9.090214,"median":-3.532909,"eighty":-0.895974,"marketCap":172522661},{"date":"2023-07-07","current":-1.940342,"twenty":-9.090214,"median":-3.532909,"eighty":-0.899395,"marketCap":165621755},{"date":"2023-07-14","current":-1.957666,"twenty":-9.090214,"median":-3.532909,"eighty":-0.906287,"marketCap":167100520},{"date":"2023-07-21","current":-1.836395,"twenty":-9.090214,"median":-3.532909,"eighty":-0.909901,"marketCap":156749161},{"date":"2023-07-28","current":-1.726673,"twenty":-9.090214,"median":-3.532909,"eighty":-0.919185,"marketCap":147383645},{"date":"2023-08-04","current":-1.795971,"twenty":-9.090214,"median":-3.532909,"eighty":-0.928329,"marketCap":153298707},{"date":"2023-08-11","current":-1.969804,"twenty":-9.090214,"median":-3.532909,"eighty":-0.937755,"marketCap":160166735},{"date":"2023-08-18","current":-1.743017,"twenty":-9.090214,"median":-3.532909,"eighty":-0.941735,"marketCap":141726485},{"date":"2023-08-25","current":-1.587507,"twenty":-9.090214,"median":-3.532909,"eighty":-0.945086,"marketCap":129081743},{"date":"2023-09-01","current":-1.639343,"twenty":-9.090214,"median":-3.532909,"eighty":-0.956324,"marketCap":133296657},{"date":"2023-09-08","current":-1.593986,"twenty":-9.090214,"median":-3.532909,"eighty":-0.958492,"marketCap":129608607},{"date":"2023-09-15","current":-1.807814,"twenty":-9.090214,"median":-3.532909,"eighty":-0.970251,"marketCap":146995128},{"date":"2023-09-22","current":-1.658782,"twenty":-9.090214,"median":-3.532909,"eighty":-0.979536,"marketCap":134877250},{"date":"2023-09-29","current":-1.619905,"twenty":-9.090214,"median":-3.532909,"eighty":-0.985303,"marketCap":131716065},{"date":"2023-10-06","current":-1.684701,"twenty":-9.090214,"median":-3.532909,"eighty":-0.991188,"marketCap":136984707},{"date":"2023-10-13","current":-1.69118,"twenty":-9.090214,"median":-3.532909,"eighty":-1.00206,"marketCap":137511571},{"date":"2023-10-20","current":-1.509751,"twenty":-9.090214,"median":-3.532909,"eighty":-1.006093,"marketCap":122759372},{"date":"2023-10-27","current":-1.503271,"twenty":-9.120812,"median":-3.537707,"eighty":-1.019689,"marketCap":122232508},{"date":"2023-11-03","current":-1.658782,"twenty":-9.120812,"median":-3.537707,"eighty":-1.028451,"marketCap":134877250},{"date":"2023-11-10","current":-1.677615,"twenty":-9.120812,"median":-3.537707,"eighty":-1.034911,"marketCap":131635733},{"date":"2023-11-17","current":-1.615988,"twenty":-9.120812,"median":-3.537707,"eighty":-1.035705,"marketCap":126800135},{"date":"2023-11-24","current":-1.924122,"twenty":-9.120812,"median":-3.537707,"eighty":-1.035705,"marketCap":150978127},{"date":"2023-12-01","current":-2.163781,"twenty":-9.120812,"median":-3.537707,"eighty":-1.035705,"marketCap":169783232},{"date":"2023-12-08","current":-4.505594,"twenty":-9.110613,"median":-3.544802,"eighty":-1.035771,"marketCap":353535971},{"date":"2023-12-15","current":-4.793186,"twenty":-9.110613,"median":-3.60865,"eighty":-1.041865,"marketCap":376102097},{"date":"2023-12-22","current":-5.402605,"twenty":-9.110613,"median":-3.686688,"eighty":-1.046438,"marketCap":423920792},{"date":"2023-12-29","current":-7.956688,"twenty":-9.120812,"median":-3.745808,"eighty":-1.059015,"marketCap":624329481},{"date":"2024-01-05","current":-8.00462,"twenty":-9.131012,"median":-3.795468,"eighty":-1.062066,"marketCap":628090501},{"date":"2024-01-12","current":-7.867672,"twenty":-9.131012,"median":-3.884844,"eighty":-1.073911,"marketCap":617344727},{"date":"2024-01-19","current":-7.388353,"twenty":-9.141211,"median":-4.008415,"eighty":-1.078488,"marketCap":579734518},{"date":"2024-01-26","current":-6.354395,"twenty":-9.131012,"median":-4.119442,"eighty":-1.078619,"marketCap":498603922},{"date":"2024-02-02","current":-6.765239,"twenty":-9.131012,"median":-4.20221,"eighty":-1.078619,"marketCap":530841245},{"date":"2024-02-09","current":-6.635138,"twenty":-9.131012,"median":-4.339366,"eighty":-1.078619,"marketCap":520632759},{"date":"2024-02-16","current":-6.12843,"twenty":-9.131012,"median":-4.37682,"eighty":-1.078619,"marketCap":480873395},{"date":"2024-02-23","current":-6.073651,"twenty":-9.131012,"median":-4.459875,"eighty":-1.082595,"marketCap":476575085},{"date":"2024-03-01","current":-8.285364,"twenty":-9.152685,"median":-4.505594,"eighty":-1.101931,"marketCap":650119339},{"date":"2024-03-08","current":-6.86795,"twenty":-9.152685,"median":-4.658612,"eighty":-1.122353,"marketCap":538900576},{"date":"2024-03-15","current":-6.864526,"twenty":-9.152685,"median":-4.78631,"eighty":-1.163594,"marketCap":538631931},{"date":"2024-03-22","current":-6.237989,"twenty":-9.152685,"median":-4.819439,"eighty":-1.201744,"marketCap":489470014},{"date":"2024-03-28","current":-7.125839,"twenty":-9.152685,"median":-4.887378,"eighty":-1.371955,"marketCap":630259092},{"date":"2024-04-05","current":-7.133855,"twenty":-9.15651,"median":-4.944847,"eighty":-1.549925,"marketCap":630968045},{"date":"2024-04-12","current":-6.733076,"twenty":-9.15651,"median":-4.976853,"eighty":-1.582323,"marketCap":595520402},{"date":"2024-04-19","current":-5.522726,"twenty":-9.15651,"median":-5.010669,"eighty":-1.603058,"marketCap":488468520},{"date":"2024-04-26","current":-5.771208,"twenty":-9.152685,"median":-5.065719,"eighty":-1.622497,"marketCap":510446059},{"date":"2024-05-03","current":-5.763193,"twenty":-9.152685,"median":-5.137904,"eighty":-1.632864,"marketCap":509737106},{"date":"2024-05-10","current":-5.900173,"twenty":-9.152685,"median":-5.17612,"eighty":-1.651056,"marketCap":547341314},{"date":"2024-05-17","current":-6.802306,"twenty":-9.152685,"median":-5.23434,"eighty":-1.663576,"marketCap":631029499},{"date":"2024-05-24","current":-5.648207,"twenty":-9.152685,"median":-5.250196,"eighty":-1.680449,"marketCap":523967191},{"date":"2024-05-31","current":-5.365414,"twenty":-9.152685,"median":-5.252552,"eighty":-1.69118,"marketCap":497733380},{"date":"2024-06-07","current":-5.143766,"twenty":-9.152685,"median":-5.262603,"eighty":-1.719691,"marketCap":477171745},{"date":"2024-06-14","current":-5.05205,"twenty":-9.15651,"median":-5.263947,"eighty":-1.733603,"marketCap":468663482},{"date":"2024-06-21","current":-4.539966,"twenty":-9.160335,"median":-5.26529,"eighty":-1.749497,"marketCap":421159014},{"date":"2024-06-28","current":-4.880081,"twenty":-9.164959,"median":-5.282272,"eighty":-1.761776,"marketCap":452710489},{"date":"2024-07-05","current":-5.044407,"twenty":-9.164959,"median":-5.287002,"eighty":-1.782905,"marketCap":467954460},{"date":"2024-07-12","current":-5.869855,"twenty":-9.164959,"median":-5.307752,"eighty":-1.813296,"marketCap":544528826},{"date":"2024-07-15","current":-6.038002,"twenty":-9.164959,"median":-5.325968,"eighty":-1.814927,"marketCap":560127308},{"date":"2024-08-02","current":-4.654611,"twenty":-9.22331,"median":-5.382384,"eighty":-1.858355,"marketCap":431794343},{"date":"2024-08-09","current":-4.4375,"twenty":-9.22331,"median":-5.382384,"eighty":-1.898763,"marketCap":449722870},{"date":"2024-08-16","current":-4.375927,"twenty":-9.22331,"median":-5.382384,"eighty":-1.922746,"marketCap":443482734},{"date":"2024-08-23","current":-4.740588,"twenty":-9.22331,"median":-5.382384,"eighty":-1.94836,"marketCap":480439628},{"date":"2024-08-30","current":-4.635397,"twenty":-9.22331,"median":-5.382384,"eighty":-1.963276,"marketCap":469778986},{"date":"2024-09-06","current":-4.481118,"twenty":-9.22331,"median":-5.382384,"eighty":-1.992315,"marketCap":454143376},{"date":"2024-09-13","current":-4.97902,"twenty":-9.22331,"median":-5.382384,"eighty":-2.006297,"marketCap":504603752},{"date":"2024-09-20","current":-5.308617,"twenty":-9.22331,"median":-5.392613,"eighty":-2.04582,"marketCap":538007099},{"date":"2024-09-27","current":-4.775651,"twenty":-9.22331,"median":-5.402605,"eighty":-2.071356,"marketCap":483993176},{"date":"2024-10-04","current":-4.312813,"twenty":-9.22331,"median":-5.402605,"eighty":-2.098777,"marketCap":437086348},{"date":"2024-10-11","current":-4.221648,"twenty":-9.22331,"median":-5.402605,"eighty":-2.13584,"marketCap":427847125},{"date":"2024-10-18","current":-4.761626,"twenty":-9.22331,"median":-5.402605,"eighty":-2.165516,"marketCap":482571757},{"date":"2024-10-25","current":-4.744094,"twenty":-9.22331,"median":-5.402605,"eighty":-2.226131,"marketCap":480794983},{"date":"2024-10-31","current":-4.740588,"twenty":-9.22331,"median":-5.402605,"eighty":-2.244588,"marketCap":480439628},{"date":"2024-11-08","current":-5.231477,"twenty":-9.225312,"median":-5.405129,"eighty":-2.271833,"marketCap":530189294},{"date":"2024-11-15","current":-5.809106,"twenty":-9.225312,"median":-5.445898,"eighty":-2.292553,"marketCap":601358704},{"date":"2024-11-22","current":-5.774753,"twenty":-9.225312,"median":-5.463564,"eighty":-2.309931,"marketCap":597802473},{"date":"2024-11-29","current":-5.888119,"twenty":-9.225312,"median":-5.498958,"eighty":-2.31901,"marketCap":609538036},{"date":"2024-12-06","current":-6.279744,"twenty":-9.225312,"median":-5.534802,"eighty":-2.33289,"marketCap":650079072},{"date":"2024-12-13","current":-5.90186,"twenty":-9.225312,"median":-5.583452,"eighty":-2.353729,"marketCap":610960528},{"date":"2024-12-20","current":-5.620165,"twenty":-9.225312,"median":-5.617263,"eighty":-2.367082,"marketCap":581799432},{"date":"2024-12-27","current":-5.496493,"twenty":-9.225312,"median":-5.622268,"eighty":-2.3962,"marketCap":568997000},{"date":"2025-01-03","current":-4.885009,"twenty":-9.225312,"median":-5.622268,"eighty":-2.406198,"marketCap":505696083},{"date":"2025-01-10","current":-5.11861,"twenty":-9.227313,"median":-5.624371,"eighty":-2.432957,"marketCap":529878456},{"date":"2025-01-17","current":-4.610184,"twenty":-9.227313,"median":-5.624371,"eighty":-2.450298,"marketCap":477246233},{"date":"2025-01-24","current":-4.850655,"twenty":-9.227313,"median":-5.624371,"eighty":-2.462386,"marketCap":502139852},{"date":"2025-01-31","current":-4.809432,"twenty":-9.227313,"median":-5.624371,"eighty":-2.492163,"marketCap":497872375},{"date":"2025-02-07","current":-4.747596,"twenty":-9.227313,"median":-5.624371,"eighty":-2.545445,"marketCap":491471158},{"date":"2025-02-14","current":-4.280394,"twenty":-9.227313,"median":-5.624371,"eighty":-2.577061,"marketCap":443106413},{"date":"2025-02-21","current":-4.555219,"twenty":-9.227313,"median":-5.624371,"eighty":-2.609749,"marketCap":471556263},{"date":"2025-02-28","current":-4.886485,"twenty":-9.227313,"median":-5.624371,"eighty":-2.682852,"marketCap":464504340},{"date":"2025-03-07","current":-4.528833,"twenty":-9.229315,"median":-5.62647,"eighty":-2.751011,"marketCap":430506348},{"date":"2025-03-14","current":-4.212868,"twenty":-9.229315,"median":-5.62647,"eighty":-2.800801,"marketCap":400471021},{"date":"2025-03-21","current":-4.682765,"twenty":-9.229315,"median":-5.62647,"eighty":-2.864367,"marketCap":445138943},{"date":"2025-03-28","current":-4.51263,"twenty":-9.229315,"median":-5.62647,"eighty":-2.887636,"marketCap":428966075},{"date":"2025-04-04","current":-3.613344,"twenty":-9.229315,"median":-5.62647,"eighty":-2.950267,"marketCap":343480914},{"date":"2025-04-11","current":-3.370294,"twenty":-9.227313,"median":-5.624371,"eighty":-3.036633,"marketCap":320376817},{"date":"2025-04-17","current":-3.564734,"twenty":-9.227313,"median":-5.624371,"eighty":-3.077604,"marketCap":338860095},{"date":"2025-04-25","current":-4.188563,"twenty":-9.229315,"median":-5.62647,"eighty":-3.116395,"marketCap":398160611},{"date":"2025-05-02","current":-4.188563,"twenty":-9.229315,"median":-5.62647,"eighty":-3.213748,"marketCap":398160611},{"date":"2025-05-09","current":-4.698968,"twenty":-9.229315,"median":-5.62647,"eighty":-3.305959,"marketCap":446679216},{"date":"2025-05-16","current":-5.195017,"twenty":-9.229315,"median":-5.62647,"eighty":-3.335282,"marketCap":468798303},{"date":"2025-05-23","current":-5.186029,"twenty":-9.229315,"median":-5.62647,"eighty":-3.341904,"marketCap":467987234},{"date":"2025-05-30","current":-5.042222,"twenty":-9.229315,"median":-5.61173,"eighty":-3.341904,"marketCap":455010118},{"date":"2025-06-06","current":-4.907403,"twenty":-9.1665,"median":-5.562525,"eighty":-3.341904,"marketCap":442844072}],"updateTime":1749328491510}}}